O5‐03‐04: THE LEWY BODY DEMENTIA ASSOCIATION RESEARCH CENTERS OF EXCELLENCE PROGRAM: TOWARD OPTIMIZING CLINICAL CARE AND CLINICAL TRIAL INFRASTRUCTURE

The Lewy Body Dementias (LBD), which include dementia with Lewy bodies (DLB) and Parkinson's disease with dementia (PDD), represent the second most common dementia syndrome after Alzheimer's disease dementia. There are several challenges associated with LBD, which include the lack of approved medications for most clinical features, lack of evidence on management principles, and absence of infrastructure for LBD clinical trials. The Lewy Body...